Revised diagnostic criteria for Alzheimer disease (AD) acknowledge a key role of imaging
biomarkers for early diagnosis. Diagnostic accuracy depends on which marker (ie, amyloid …

Objective – In this paper, the current neuroimaging literature is reviewed with regard to
characteristic findings in mild cognitive impairment (MCI). Particular attention is drawn to the …

Background: Current research criteria for Alzheimer’s disease (AD) include cerebrospinal
fluid (CSF) biomarkers into the diagnostic algorithm. However, spreading their use to the …

Background and Purpose—MRI is more sensitive than CT for detection of age-related white
matter changes (ARWMC). Most rating scales estimate the degree and distribution of …

Background Epidemiologic and animal studies have suggested that dietary fish or fish oil
rich in ω-3 fatty acids, for example, docosahexaenoic acid and eicosapentaenoic acid, may …

Background: Tau protein and the 42-amino acid form of β-amyloid (Aβ42) measured in
cerebrospinal fluid (CSF) have been proposed as potential biochemical diagnostic markers for …

Background Alzheimer's disease (AD) pathology is common in patients with amnestic mild
cognitive impairment (aMCI) without dementia, but the prevalence of AD pathology in patients …

Nerve growth factor (NGF) is important for the survival and maintenance of central cholinergic
neurons, a signalling system impaired in Alzheimer’s disease. We have treated 3 patients …

The present study evaluated the clinical course of patients with mild cognitive impairment (MCI),
the pattern of electroencephalography (EEG) changes following cognitive deterioration, …

Objective: In the Leukoaraiosis and Disability (LADIS) Study, 11 European centers are
evaluating the role of age-related white matter changes (ARWMC) as an independent …